Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GCS-100 in Chronic Kidney Disease
NCT01843790Phase 2Completed
- Sponsor
- La Jolla Pharmaceutical Company
- Start
- Jun 2013
- Primary completion
- Feb 2014
- Modality
- Polysaccharide, Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of GCS-100 in chronic kidney disease (CKD), sponsored by La Jolla Pharmaceutical Company. Started Jun 2013; status: completed.
02
Drugs
GCS-100
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT01843790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01843790.